June 3, 2026
Ismail Elkhatib
Share
https://pubmed.ncbi.nlm.nih.gov/40414507/
Linerixibat for Cholestatic Pruritus in PBC: Phase 3 Results from the GLISTEN Trial
July 13, 2026
Can POCUS guide volume management in cirrhosis patients with acute kidney injury?
May 18, 2026
Can Efruxifermin Reverse Fibrosis in Compensated MASH Cirrhosis?
April 28, 2026
